Characterisation of the histone acetyltransferase KAT7 as a novel target for radiosensitisation
<p>Radiotherapy is one of the pillars of modern cancer therapy. However, side effects associated with normal tissue toxicity limit the effectiveness of this treatment. It is therefore desirable to develop tumour-specific radiosensitising agents, which can increase tumour cell kill without incr...
Tác giả chính: | Bittner, M |
---|---|
Tác giả khác: | Higgins, G |
Định dạng: | Luận văn |
Được phát hành: |
2017
|
Những quyển sách tương tự
-
Histone Deacetylases and Their Potential as Targets to Enhance Tumour Radiosensitisation
Bằng: Jennifer Antrobus, et al.
Được phát hành: (2022-03-01) -
The NLRP11 Protein Bridges the Histone Lysine Acetyltransferase KAT7 to Acetylate Vimentin in the Early Stage of Lung Adenocarcinoma
Bằng: Rui Yang, et al.
Được phát hành: (2023-09-01) -
Myst2/Kat7 histone acetyltransferase interaction proteomics reveals tumour-suppressor Niam as a novel binding partner in embryonic stem cells
Bằng: Mercedes Pardo, et al.
Được phát hành: (2017-08-01) -
The histone deacetylase inhibitor panobinostat as a radiosensitiser in bladder cancer
Bằng: Groselj, B
Được phát hành: (2014) -
Histone deacetylase inhibitors as radiosensitisers: Effects on DNA damage signalling and repair
Bằng: Groselj, B, et al.
Được phát hành: (2013)